Thursday, November, 21, 2019 04:45:54

The agreement between Harvest one and Holland and Barret aim to ensure the supply of Satipharm CBD Gelpell Capsules to 841 stores in the UK and Ireland.

Global cannabis company Harvest Inc. has reportedly announced an agreement with Holland and Barret, one of the world’s leading health and wellness retailers, for the distribution of its proprietary Satipharm CBD 10mg Gelpell.

According to terms of the deal, Harvest one is expected to supply Satipharm CBD 10mg Gelpell online through the Holland and Barret website and to 841 of their stores. The distribution of the first shipment which arrived on 5th of June 2019, is to be carried out in stores throughout the UK.

According to reliable sources, Satipharm is expected to support the overall distribution strategy with product training and education.

Harvest One CEO, Grant Froese apparently commented that the agreement is vital to their global strategy. The fact that a leading company such as Holland and Barret trusts their products showcases the success the firm’s investments in commercial strategy and manufacturing standards are achieving, Froese mentioned. Further on, Froese claimed that company’s intends to increase the demand for Satipharm CBD Gelpell capsules with help of both online and instore activity.

A spokesperson from Holland and Barret commented on the swift growth of the CBD industry and promised that the company will remain at the forefront of the sphere through the growth and creation of innovative products that may be valuable to the market. The spokesperson further elaborated on the functions of the capsule, claiming that it gives the customers a measurable dose of CBD through the day.

For the record, Satipharm CBD Gelpell capsules are EU GMP certified products, manufactured in Switzerland under highly standardized and controlled laboratory conditions which ensure that every capsule delivers a constant measured dose of CBD. Satipharm has proven to have bioavailability up to 30% higher after having undergone clinical trials of Stage I and II. Source Credits – https://www.prnewswire.com/news-releases/harvest-one-announces-new-satipharm-supply-agreement-300863279.html